MEDPURA ZINC OXIDE 20%- medpura zinc oxide 20% ointment 
Akron Pharma Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

MEDPURA
Zinc Oxide 20% Ointment
Regular Strength

Active Ingredient

Zinc Oxide 20%

Purpose

Skin Protectant

Uses

Warnings

For External Use Only

When using this product

avoid contact with the eyes

Stop use and ask a doctor if

if condition worsens or does not improve within 7 days. This may be a sign of a serious condition.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

Other Information

Inactive Ingredients

alovera gel, mineral oil, white petrolatum

Questions and Comments?

Call toll-free 1-877-225-6999

2oz

3oz

16oz

MEDPURA ZINC OXIDE 20% 
medpura zinc oxide 20% ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71399-0245
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE20 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
MINERAL OIL (UNII: T5L8T28FGP)  
WHITE PETROLATUM (UNII: B6E5W8RQJ4)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71399-0245-21 in 1 CARTON09/12/2022
156.7 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:71399-0245-31 in 1 CARTON11/04/2021
285 g in 1 TUBE; Type 0: Not a Combination Product
3NDC:71399-0245-6454 g in 1 JAR; Type 0: Not a Combination Product11/04/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34711/04/2021
Labeler - Akron Pharma Inc. (067878881)

Revised: 3/2023
Document Id: 19cedfa7-7a2f-4f01-9393-f1be0308d584
Set id: 3a63aaea-087e-4115-8478-64d416e6085f
Version: 3
Effective Time: 20230311
 
Akron Pharma Inc.